Is Fresenius Medical Care AG (FMS) Halal?
Shariah Screening — 5 Standards
Based on financial data from December 2025
| Standard | Debt Ratio | Cash Ratio | Receivables | Income | Status |
|---|---|---|---|---|---|
| AAOIFI | 81.6% / 30% | 13.8% / 30% | 27.7% / 30% | 0.35% / 5% | ✗ NOT HALAL |
| DJIM | 81.6% / 33% | 13.8% / 33% | 27.7% / 33% | 0.35% / 5% | ✗ NOT HALAL |
| MSCI | 34.8% / 33% | 5.9% / 33% | 11.8% / 33% | 0.35% / 5% | ✗ NOT HALAL |
| S&P | 81.6% / 33% | 13.8% / 33% | 27.7% / 33% | 0.35% / 5% | ✗ NOT HALAL |
| FTSE | 34.8% / 33% | 5.9% / 33% | 11.8% / 50% | 0.35% / 5% | ✗ NOT HALAL |
Financial Highlights
Profitability
| Gross Margin | 25.6% | |
| Operating Margin | 11.7% | |
| Net Margin | 5.0% | |
| Return on Equity (ROE) | 7.9% | |
| Return on Assets (ROA) | 3.6% |
Cash Flow & Balance Sheet
| Operating Cash Flow | $2.7B |
| Free Cash Flow | $1.8B |
| Total Debt | $10.8B |
| Debt-to-Equity | 75.7 |
| Current Ratio | 1.3 |
| Total Assets | $31.0B |
Price & Trading
| Last Close | $22.39 |
| 50-Day MA | $22.98 |
| 200-Day MA | $24.78 |
| Avg Volume | 621K |
| Beta | 0.9 |
|
52-Week Range
$20.95
| |
About Fresenius Medical Care AG (FMS)
Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, the United States, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure. The company operates through Care Delivery and Care Enablement segments. It also develops, manufactures, and distributes various health care products, including hemodialysis machines, peritoneal dialysis cyclers, peritoneal dialysis solutions, hemodialysis concentrates, solutions and granulates, bloodlines, renal pharmaceuticals, systems for water treatment, and acute cardiopulmonary and apheresis products. In addition, the company develops, acquires, and in-licenses renal pharmaceuticals; offers renal medications and supplies to patients at homes or to dialysis clinics; and provides vascular specialty, ambulatory surgery center, physician nephrology practice management, pharmacy and other services. The company sells its products to dialysis clinics, hospitals, and specialized treatment clinics, as well as through local sales forces, independent distributors, dealers, and sales agents. The company was incorporated in 1996 and is headquartered in Bad Homburg, Germany.
Related Halal Stocks in Healthcare
Frequently Asked Questions
Is Fresenius Medical Care AG (FMS) halal to invest in?
Based on our screening using AAOIFI Standard 21 (the strictest methodology), Fresenius Medical Care AG is Not Halal. The company fails one or more screening criteria. We screen against all 5 major standards: AAOIFI, DJIM, MSCI, S&P, and FTSE.
What is Fresenius Medical Care AG's debt ratio?
Fresenius Medical Care AG's debt ratio is 81.6% under the AAOIFI standard (which uses market capitalization as the denominator). The AAOIFI threshold is 30%. Under MSCI and FTSE (which use total assets as the denominator), the debt ratio is 34.8%.
What are Fresenius Medical Care AG's key financial metrics?
Fresenius Medical Care AG has a market capitalization of $12.7B, trailing P/E ratio of 11.4, and revenue of $19.6B. The company maintains a gross margin of 25.6% and a net margin of 5.0%. Return on equity stands at 7.9%.
How often is the screening data updated?
Our screening data is updated regularly using the latest available financial statements and market data. Stock prices and market caps are refreshed frequently, while financial statements are updated quarterly when companies report earnings.
Disclaimer: HalalStockGuide.com provides Shariah compliance screening for educational and informational purposes only. This is not a fatwa, financial advice, or a recommendation to buy or sell any security. Screening results are based on publicly available financial data and established methodologies. Always consult a qualified Islamic scholar and a licensed financial advisor before making investment decisions.